The Incidence and Costs of Adverse Events Associated with Antidepressants: Results from a Systematic Review, Network Meta-Analysis and Multi-Country Economic Model.
Benjamin KearnsKaty CooperMartin OrrMunira EssatJean HamiltonAnna CantrellPublished in: Neuropsychiatric disease and treatment (2022)
Trazodone generally had the best safety profile of the antidepressants evaluated. This led to healthcare costs being lowest for trazodone in all nine European countries, emphasising the importance of considering rates of adverse events when choosing a pharmacological treatment to treat symptoms of depression.